More in general, IDO1-mediated TRP depletion establishes an immunosuppressive environment, amplifying tolerogenic antigen-presenting cells (APC), expanding Treg and downregulating cytotoxic T-cell activity, thus preventing immune response to tumor cells [17]. The gene discussed is IDO1; the disease is neoplasm.